Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
August 28, 2019 –
Concluding their insights on the management of interstitial lung disease (ILD), experts look forward to the future treatment paradigm.
August 28, 2019 –
A comprehensive breakdown of treatment strategies for interstitial lung disease in systemic sclerosis.
August 21, 2019 –
Experts reflect on the prevalence and implications of interstitial lung disease in systemic sclerosis.
August 21, 2019 –
Specific considerations are given for the identification and management of progressive fibrosing–interstitial lung disease.
August 14, 2019 –
Regarding interstitial lung disease, Alicia M. Hinze, MD, elucidates immunosuppressive approaches and beneficial lifestyle changes.
August 14, 2019 –
Shifting their focus to pharmacological management of interstitial lung disease (ILD), experts review approved treatment options.
August 08, 2019 –
Highlights from clinical guidelines and therapeutic goals related to the management of interstitial lung disease (ILD).
August 08, 2019 –
An outline of the many factors that play into the direct and indirect costs of interstitial lung disease (ILD).
July 31, 2019 –
An expert identifies who manages a patient with interstitial lung disease (ILD) and what factors play into the selection of therapy.
July 31, 2019 –
Alicia M. Hinze, MD, reflects on optimal diagnostic strategies used to identify interstitial lung disease (ILD).
